Genetic evidence indicates that the PriA (SecY) protein of Escherichia coli functions as a membrane integrated signal sequence receptor in protein "export"-i.e., in protein translocation across (or integration into) the plasma membrane. We have raised antibodies in rabbits against two synthetic peptides representing the hydrophilic N-or Cterminal region of PrIA. Using these antibodies as probes in cell fractionation experiments, we confirm that PrlA is an integral membrane protein of the plasma membrane of E. coli. Fab fragments prepared from each of the two antisera specifically inhibit protein export by interfering with the binding of preproteins to the plasma membrane. Inhibition of preprotein binding and export by Fab fragments was shown in a cell-free translocation system: precursors for LamB (an integral membrane protein) and for a truncated form of MalE (a periplasmic protein) were first synthesized in a membrane-depleted E. coli-derived cell-free translation system followed by posttranslational incubation with inverted vesicles derived from the plasma membrane of E. coli. Our data thus indicate that the N and C termini of PrlA are exposed to the cytoplasm. We discuss the possibility that the transmembrane segments of PriA could be arranged in the lipid bilayer in a cylindrical fashion, thereby delimiting a protein conducting channel, with a signal sequence binding domain represented, at least in part, by the N and C termini of PrlA. Such a channel would also contain a "stoptransfer" sequence binding domain that in response to a stop-transfer sequence would open the cylindrical channel to the lipid bilayer and permit displacement of the polypeptide from the channel to the lipid bilayer, resulting in membrane integration.
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Genetic approaches have identified several genes that function in protein "export"-i.e., in protein translocation across or integration into the plasma membrane of Escherichia coli (for review, see refs. 1 and 2) . The products of these genes have been proposed to be components of the E. coli protein translocation machinery.
priA is a member of this group of genes. It has been discovered as a suppressor of signal sequence mutations (3) .
Certain alleles of priA have been shown to restore export of proteins containing defective signal sequences without affecting the translocatability of proteins containing "wildtype" signal sequences (4) . The PrlA protein has therefore been proposed to function in signal sequence recognition.
After the discovery of priA, a gene termed sec Y was identified. A temperature-sensitive allele of secY conferred a temperature-sensitive phenotype for protein translocation and growth at the restricted temperature (5). Expression of secY was found to be essential for protein translocation (6) .
Sec Y (7) as well as priA (8) have been shown to be located at the promoter-distal part of the spc ribosomal protein operon of E. coli and to represent one and the same gene.
The sequence of the priA (sec Y) gene has been established (9) . From the deduced amino acid sequence (9) and from N-terminal sequence analysis of the overproduced protein (10) , it is known that PrlA consists of 443 amino acids with a calculated mass of49 kDa. Hydropathy analyses showed that PrlA contains at least eight hydrophobic regions that could serve as membrane spanning segments. On the bases of its abnormal electrophoretic mobility, its partitioning into the nonionic detergent Nonidet P-40, and cell fractionation data, PrlA has been proposed to be an integral membrane protein of the E. coli plasma membrane (11) .
Using a cell-free E. coli-derived translocation system, Fandl and Tai (12) Synthesis of Peptides. Peptides corresponding to the N-or C-terminal region of PrIA (see Fig. 1 ) were generously synthesized by R. Lerner (Research Institute Scripps Clinic) using solid-phase methods (13) . An additional cysteine for the purpose of coupling to the protein carrier was added to the sequence (see Fig. 1 ).
Coupling the Synthetic Peptides to Carrier Protein. Peptides were coupled to the carrier protein keyhole limpet hemocyanin (KLH) through their cysteine residues with mmaleimidobenzoyl-N-hydroxysuccinimide ester (MBS) as coupling reagent (14) . KLH (25 mg) was dissolved into 750 ,ul of 10 mM sodium phosphate buffer (pH 7.2) and dialyzed against the same sodium phosphate buffer for 3 hr at 4°C. The dialyzed KLH solution was centrifuged for 5 min at 10,000 x g to remove undissolved material and the volume was Abbreviations: INVs, inverted vesicles derived from the Escherichia coli plasma membrane; KLH, keyhole limpet hemocyanin; MBS, m-maleimidobenzoyl-N-hydroxysuccinimide; TEA, triethanolamine; BSA, bovine serum albumin.
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Cell Biology: Watanabe and Blobel adjusted to 1.25 ml. To 1 ml of this KLH solution, 275 A.l of 10 mM sodium phosphate buffer (pH 7.2) and 425 pA of MBS (6 mg/ml) in dimethylformamide were added. The reaction mixture was stirred for 30 min at room temperature and passed through Sephadex G-25 equilibrated with 50 mM sodium phosphate buffer (pH 6.0). Peak fractions were pooled by measuring A280. To 0.75 ml of KLH-MBS (6 mg/ml) was added 1 ml of peptide solution (5 mg/ml) [in 50 mM sodium phosphate buffer (pH 6.0)], and the pH was adjusted to 7.0-7.5 with 1 M NaOH. The mixture was stirred for 3 hr at room temperature and stored at -200C until used for immunization.
Preparation of Anti-peptide Antibodies. New Zealand White rabbits were injected subcutaneously at four sites with 240 Ag of peptide-coupled KLH emulsified with complete Freund's adjuvant (1:1) for the primary injection. Subsequent injections of antigen (240 ,ug per rabbit) emulsified with incomplete Freund's adjuvant were at 2-week intervals. Sera were collected 1 week after the third injection.
Preparation of Fab Fragments. IgG was isolated from antisera by ammonium sulfate precipitation, followed by DEAE-Sephadex chromatography (15) . Fab fragments were prepared from IgG according to Garvey et al. (16) . IgG was digested with papain and dialyzed against 0.01 M acetate buffer (pH 5.5). The dialyzed sample was applied to a CM-cellulose column and elution was carried out by the stepwise addition of 0.05, 0.1, 0.225, and 0.45 M sodium acetate (pH 5.5). The fraction eluted by 0.05 M buffer was collected, concentrated by a Millipore immersible CX-10 ultrafiltration unit, and passed through a Sephadex G-25 column to change the buffer to 0.05 M triethanolamine (TEA)-OAc (pH 7.5). The concentration of Fab fragments was determined by the bicinchoninic acid protein assay (Pierce) with bovine serum albumin (BSA) as standard. Subcellular Fractionation. Subcellular fractionation was done according to Schnaitman (17) . E. coli strain MRE 600 cells were grown to A60 = 1.8 in a medium containing (per liter) 5.6 g of KH2PO4 (anhydrous)/28.9 g of K2HPO4 (anhydrous)/10 g of yeast extract/10 g of bactotryptone/10 g of glucose. Cells were resuspended (1 g/ml) in buffer A (50 mM TEA-OAc, pH 7.5/250 mM sucrose/1 mM EDTA/1 mM dithiothreitol/0.5 mM phenylmethylsulfonyl fluoride, and passed through a French press twice at 4000 psi (1 psi = 6.9 kPa). The cell lysate was freed of unbroken cells and cell debris (10 min at 3000 x g) and the resulting supernatant (homogenate) was centrifuged for 2 hr at 150,000 x g,,. The pellet (total membranes) derived from 1 liter of culture was resuspended in 2 ml of buffer A by using a loosely fitting Dounce homogenizer and 0.5 ml of this suspension was layered on top of a sucrose gradient in buffer A according to Schnaitman (17) . After centrifugation, the gradient was divided into four fractions; top, plasma membrane, intermediate, and outer membrane fraction. Aliquots containing 100 ,g of protein of homogenate, supernatant, total membrane, and each of the four fractions were analyzed by NaDodSO4/ PAGE and immunoblotting (see below). INV of the plasma membrane used for posttranslational translocation (see below) were prepared as described (18) .
Posttranslational Translocation Assay. mRNA (200 ng) for LamB or a truncated form of MalE lacking 49 C-terminal residues but containing 7 additional residues not found in the original sequence and a termination codon (unpublished data) and referred to as MalE* was translated in an E. coli cell-free translation system depleted of plasma membranes as described (18) . After translation, the mixture was centrifuged for 30 min at 30 psi in the Airfuge rotor A100/18 to sediment ribosomes. The postribosomal supernatant was passed twice through Sephadex G-25 equilibrated with 40 mM TEA-OAc, pH 7.5/140 mM KOAc/11 mM Mg(OAc)2/0.8 mM spermidine/0.1 mM EDTA. The G-25 postribosomal supernatant was supplemented with 5 mM ATP, 0.5 A280 unit of high salt washed INV per ml, and, where indicated, Fab fragments and peptides. After incubation for 60 min at 250C, the reaction mixture was treated with proteinase K (300 .tg/ ml) on ice for 30 min. The digestion was stopped by the addition of 10 mM phenylmethylsulfonyl fluoride and an equal volume of20% trichloroacetic acid. The precipitate was processed for NaDodSO4/PAGE. In some cases (see Fig. 5 ), membrane sedimentation was performed as described (18) . NaDodSO4/PAGE. Procedures for NaDodSO4/PAGE and subsequent autoradiography of dried slab gels were as described (19) . The samples for NaDodSO4/PAGE were precipitated with an equal volume of 20% trichloroacetic acid, and the precipitate was resuspended in 0.5 M Tris base containing 6.25% NaDodSO4 by sonication and subsequent incubation at 370C for 1 hr. Thereafter, the samples were reduced with dithiothreitol (100 mM) at 370C for 1 hr or, in one case (see Fig. 2 , lane 10), at 100'C for 5 min. Acrylamide gradient gels (10-15%) were used throughout except in one case (lane 11), where a 22.5% acrylamide gel was used.
To quantitate the radioactivity in a specific polypeptide species in the dried gel, we used a Beta Scanning System (Automated Microbiology Systems, San Diego, CA).
Immunoblotting. After NaDodSO4/PAGE, proteins were electrophoretically blotted onto nitrocellulose in 20 mM Tris base/150 mM glycine/20% methanol at 80 V for 20-24 hr. The nitrocellulose blots were incubated for 1 hr in 3% BSA/140 mM NaCl/10 mM KPO4, pH 7.5. Blots were then washed with distilled water and incubated overnight with anti-peptide antisera diluted 1:50 in buffer B (1% BSA/140 mM NaCl/10 mM KPO4, pH 7.5/0.1% Triton X-100/0.02% NaDodSO4), washed with buffer B without antisera and BSA, incubated overnight with l25l-protein A diluted 1:2500 in buffer B, washed with 560 mM NaCl/10 mM KPO4, pH 7.5/0.5% Triton X-100/0.1% NaDodSO4, dried, and exposed to Kodak XAR film.
RESULTS

Synthetic Peptides Corresponding to N-and C-Terminal
Regions of the PrIA Protein. A hydropathy analysis of the primary protein sequence using the algorithm of Eisenberg et al. (20) suggested that PrlA might contain as many as eight hydrophobic segments (Fig. 1 , open boxes) that would be long enough to span the membrane and two hydrophobic segments (stippled boxes) that would be too short to span the membrane as an a-helix. Two peptides were synthesized that corresponded to hydrophilic regions at the N or C terminus of PrlA (bars). These hydrophilic segments of PrIA were chosen for immunization because they are likely to be exposed to the hydrophilic environment of the membrane, although no information was available at that time as to whether these domains are exposed on the cytoplasmic or on the periplasmic side of the plasma membrane (see below).
Detection of PrIA Protein Expressed by Chromosomal Gene.
E. coli cells of the MRE 600 strain were broken by passage through a French press. A fraction representing the plasma membranes was prepared. Equal amounts of protein of both the homogenate (Fig. 2, lane H) and the plasma membrane fraction (lane PM) were analyzed by NaDodSO4/PAGE and then either stained with Coomassie blue (Fig. 2 Left) or blotted onto nitrocellulose sheets and probed with preimmune sera or antisera against the synthetic peptides (Fig. 2 Center). Both the anti-N and the anti-C antisera reacted strongly with a 35-kDa protein present in the cell homogenate and the plasma membrane fraction.
Ito (6) (20) . Open boxes, stretches of hydrophobic amino acid residues long enough to span the membrane; stippled boxes, stretches of hydrophobic amino acid residues but not long enough to span the membrane.
sample was boiled in NaDodSO4 prior to electrophoresis (Fig. 2, lane 10) . Moreover, an anti-C reactive polypeptide, now migrating at 42 kDa, was detected when the plasma membrane fraction was electrophoresed in a more highly crosslinked gel (lane 11). Taken together, these data show that the polypeptide detected by the anti-N and the anti-C antisera is PrlA. From a comparison ofband intensities in the homogenate and plasma membrane fractions, it is clear that PrlA is enriched in the plasma membrane fraction (Fig. 2) .
Subcellular Localization of PriA. To determine the location of PrlA, we fractionated MRE 600 cells according to Schnaitman (17) (Fig. 3 NaDodSO4/PAGE. The polypeptides were either stained (Fig. 3A ) or blotted onto nitrocellulose and then probed with anti-C antisera (Fig. 3B) , anti-LamB antisera (Fig. 3C) , or anti-MalE antisera (Fig. 3D) . Most of PrlA sedimented with the crude membrane fraction (Fig. 3B, Cell Biology: Watanabe and Blobel detectable LamB and therefore of outer membranes. MalE (a soluble protein in the periplasmic space) was found primarily in the soluble fraction (Fig. 3D, lane 2) . The small amount present in the crude membrane fraction sedimented at the top of the gradient (lane 4). Taken together, these cell fractionation data demonstrate that PrlA is associated exclusively with the plasma membrane. To examine whether PrlA is an integral membrane protein as predicted from the analysis of hydrophobicity (Fig. 1) , we incubated the plasma membrane fraction either at alkaline pH (pH 11.5-12.5), with high salt (1 M KOAc) or with EDTA (25 mM), and separated the extracted material from the membrane by differential centrifugation. Neither incubation procedure extracted PrlA, indicating that it is an integral membrane protein (data not shown). exposed to the cytoplasm (i.e., on the surface of INV) and if they would play a role in signal sequence recognition, our anti-N or anti-C antibodies might conceivably react with these domains and thereby inhibit translocation (integration) in a cell-free system.
We therefore prepared IgG from preimmune sera and the anti-N and the anti-C antisera and tested them in a posttranslational translocation system. The latter consisted of an E. coli translation system that was programmed with in vitro transcribed LamB mRNA and was posttranslationally incubated with INV. We had previously demonstrated that LamB, although its final location is in the E. coli outer membrane, is integrated into INV suggesting that, in vivo, this protein is first integrated into the plasma membrane and subsequently transported to the outer membrane (18) . In the presence of both the anti-N or the anti-C (but not the preimmune) IgG, posttranslational integration of pre-LamB into INV is inhibited (data not shown).
As inhibition of integration could have resulted from aggregation of PrlA in the plane of the membrane by the bivalent IgGs, we prepared monovalent Fab fragments and tested them in the posttranslational translocation system (Fig. 4) (Fig. 5) . Indeed, only a small amount of precursors of MalE* and LamB bound to INV (compare lanes 8 and 7) and none was exported (lane 9) in the presence of anti-C Fab fragments. Inhibition of binding (and export) by anti-C Fab fragments was reversed when C peptide was also present (lanes 10-12) . In the presence of both C peptide and anti-C Fab fragments, the amount of exported chain was similar to that observed in the absence of Fab fragments (lanes 1-3) or to that in the presence of Fab fragments prepared from preimmune sera (lanes [4] [5] [6] . Results similar to those with the anti-C Fab fragments (lanes 7-12) were obtained with anti-N Fab fragments (data not shown).
DISCUSSION
Our results suggest that precursors of secretory and integral membrane proteins bind to PrlA of the E. coli plasma membrane prior to their translocation across or integration into the plasma membrane. This conclusion is based on data obtained with antibodies, one against a peptide representing the N-terminal region of PrlA and the other representing its C-terminal region. In a cell-free translocation (integration) system consisting of an E. coli translation system supplemented with INVs derived from the E. coli plasma membrane, Fab fragments prepared from IgG against either of these two peptides inhibited integration of LamB or translocation of MalE*. Inhibition was observed to result from interference by the Fab fragments in the binding of the precursors to the membrane and is specific as it is completely reversed in the presence of the corresponding peptides. Taken together, these data indicate that binding of the precursor to PrlA is required for subsequent translocation across or integration into the membrane. As genetic data suggest that PrlA functions as a signal receptor (1), binding of the precursors to PrlA is likely to occur via their signal sequence.
Our finding here that Fab fragments against N-or Cterminal peptides of PrlA inhibit precursor binding to INV indicate that both N-and C-terminal regions of PrIA are exposed to the cytoplasm (PrIA therefore must contain an even number of transmembrane segments; see also ref. 21) and that both regions might be involved in signal sequence recognition, either directly or indirectly. If the transmembrane segments of PrIA were arranged in the membrane in a cylindrical fashion, the N-and C-terminal regions might form a distinct cytoplasmically exposed domain. If this domain would function in signal sequence recognition, Fab fragments would interfere with precursor binding by blocking access of the signal sequence to this domain. Alternatively, the N-and C-terminal domains of PrlA may not constitute a signal sequence recognition domain. Binding of Fab fragments to these regions of PrlA might interfere indirectly-e.g., by steric hindrance-with signal sequence binding to another domain.
A cylindrical arrangement of the 8 (or perhaps 10) transmembrane segments of PrlA could also provide for a central channel across the membrane through which chain translocation could occur (11, 21 We thank Dr. Richard Lemer for the synthesis of the two peptides used in this study, Dr. Matthias Muller for the production of antisera against the two peptides, and Drs. Thomas Silhavy and Nancy Trun for communicating their results showing cross-reactivity of the two peptide antisera with an overexpressed PrlA fusion protein. This work was supported by National Institutes of Health Grant GM27155.
